StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 16, 2026Score 0/30
$0.27−0.01 (-3.74%)

Close on Nov 20, 2026Market cap $2.89MP/E –Yield –

Gelteq free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -A$5.52M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Jun 30, 2025-A$5.52M–
FY2024Jun 30, 2024-A$1.07M–
FY2023Jun 30, 2023-A$1.80M–

More Gelteq figures

See a number that looks wrong?